Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Scrip 100 - Policy

The Outcomes-Based Reimbursement Experiment

US payers and drug companies are showing interest in outcomes-based contracts and even implementing some but whether they will become the reimbursement arrangements of the future remains highly uncertain.

BioPharmaceutical Commercial Market Access

Jimenez: "Huge Sense Of Urgency" To Implement Outcomes-Based Systems In Europe

Joe Jimenez, CEO of Novartis and EFPIA president talks about why the acceleration towards an outcomes-based healthcare system is so important to Europe, and to the reputation of the pharmaceutical industry.

Europe Policy Reimbursement
Advertisement

 

Click to download in PDF

UsernamePublicRestriction

Register

Advertisement